Introduction
Introduction
Multiple sclerosis (MS) is the major immune-mediated demyelinating human disease, affecting more than 2.5 million people [1] . It is characterized by varying amounts of demyelination, remyelination, inflammation, gliosis and axonal injury [1, 2] [5] . Based on these findings, Lassmann suggested that progression to progressive MS is associated with the development of a compartmentalized immune response, including intrathecal antibody production trapped behind a closed blood-brain barrier [6, 7] . The currently available antiinflammatory, immunomodulatory or immunosuppressive therapies which successfully reduce the severity and rate of relapses, however, frequently fail to prevent clinical and pathological deterioration of patients with progressive MS [6] . [33, 34] . Gene ontology information was assigned to the differentially expressed probe sets employing DAVID (database for annotation, visualization and integrated discovery) [35] . In those cases where multiple probe sets matched to a single official gene symbol, the probe set with the lowest q-value was selected for further analyses. Significantly enriched pathways were selected from the biological process category of the gene ontology database at a false discovery rate of 1.0% [35, 36] .
. In the majority of patients, the disease starts with a relapsing course (relapsing/remitting MS), followed by a progressive phase (secondary progressive MS) years later. In other patients, the relapsing form is missing and the disease is progressive right from the beginning (primary progressive MS). The mechanisms responsible for lesion induction and progression are complex and heterogeneous, and likely reflect different causes and immunopathogenetic mechanisms [3, 4]. A pathohistological comparison revealed that while focal, heavily inflamed, white matter plaques dominate in acute, relapsing MS, a more diffuse inflammatory process that affects the whole central nervous system is associated with massive cortical demyelination and diffuse axonal injury in progressive MS
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Materials and methods
Experimental design
Histological and immunohistological examination
Random forest machine learning algorithm
The LeFE (learner of functional enrichment) random forest machine learning algorithm was employed to link the gene expression profiles of the spinal cords to the amount of demyelination obtained by MBP immunohistology [37] . The 45, 101 probe sets of the array were reduced to 19,238 unique official gene symbols using MatchMiner [38] . The biological processes of the gene ontology database were selected to arrange the genes into functionally related categories [36] .
Results
TMEV-induced demyelinating disease
The TMEV-infected mice showed a progressively declining performance in the rotarod assay. At 196 dpi the rotarod performance was reduced to 53.4% Ϯ 4.4% of the baseline measurement at 0 dpi (Fig. 1) (Fig. 3) . 
Analysis of major transcriptional changes in Theiler's murine encephalomyelitis
To identify genes differentially expressed between TMEV-and mock-infected mice, we employed the spline-based method embedded in EDGE [31, 32] (Table S2) [35, 36] . These functional annotation clusters were related to immune response, antigen processing and presentation of exogenous [42] . 
Machine learning approach to identify pathways related to demyelination
Fig. 5 Temporal changes of leucocytic infiltrates and demyelination in the spinal cord. Box and whiskerplots show the median and quartiles of the density of (A) CD3, (B) CD45R/B220, (C) IgG, (D) CD107b ϩ cells and (E)
Immunohistological verification of microarray results
To [55] . Another microarray study of progressive MS revealed a down-regulation of DHCR7 not only in the lesions but additionally in the normal appearing white matter, suggesting that the downregulation of cholesterol biosynthesis precedes demyelination [54] . At least 70% of myelin dry weight consists of lipids, especially cholesterol [62] , and cholesterol availability represents a rate limiting factor for myelination [63] . Mice with a conditional FDFT1 mutation in oligodendrocytes display a robust quantitative impairment of myelination without ultrastructural defects or massive biochemical alterations of the generated myelin [63] [43] . The present study showed an association between demyelination and multiple categories centred on an up-regulated TLR4 expression. In the normal human central nervous system TLR4 expression is restricted to microglia, whereas in MS lesions microglia/macrophage as well as astrocytic expression is described [68] . In contrast, TLR4 expression has been observed in meninges, choroid plexus and circumventricular organs in the normal rat brain. However, after LPS stimulation TLR4 was also detected in rat microglial cells [69] . Activation of TLR4 in Theiler's murine encephalomyelitis is suggested to be induced through damage-associated molecular patterns (alarmins) such as high mobility group box protein-1 and S100 proteins from necrotic cells and fragmented hyaluronic acid from the extracellular matrix [70] [71] [72] . Interestingly TLR-4 is known to promote precursor B cell maturation, and could be a potential co-stimulatory signal for the marked up-regulation of the intrathecal humoural immune response already described in the current study [73] . Furthermore, activation of macrophages through TLR4 induces TNF-␣ expression [74] . Notably in this study, two clusters of functionally related genes were found to be involved in processes which activate pathways resulting in the formation of TNF. TNF-␣-signalling represents a well-described pathway leading to a downregulation of myelin synthesis and oligodendrocyte apoptosis [75] [76] [77] . TLR4-mediated microglial activation in vitro leads to enhanced oligodendroglial and neuronal toxicity [78] . In contrast, the outcome of TLR4 activation of microglia/macrophages in vivo is more complex and can be rather beneficial [79] [80] [81] [82] [83] . For example, TLR4-activated microglia induce the proliferation of oligodendrocyte progenitor cells in vivo [82] [64] . The presented results are in accordance with a microarray study from progressive MS, which revealed many differentially expressed genes operative in neural homeostasis [54] . Another microarray study of MS revealed that neuron-specific genes are generally decreased in the lesions [55] 
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